ALPHA TEKNOVA, INC. Effective Tax Rate
ALPHA TEKNOVA, INC. (TKNO) reported Effective Tax Rate of -1.00% for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateContinuingOperations · last filed 2026-08-06
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, percent for the quarter ending 2026-06-30 was -1.00%.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, percent for the quarter ending 2026-03-31 was -1.00%.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, percent for the quarter ending 2025-09-30 was -1.90%, a 2000.00% decline year-over-year.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, percent for the quarter ending 2025-06-30 was -0.50%, a 600.00% decline year-over-year.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, percent for fiscal 2025 was -0.30%, a 200.00% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, percent for fiscal 2024 was 0.30%, a 62.50% decline from fiscal 2023.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, percent for fiscal 2023 was 0.80%, a 79.49% decline from fiscal 2022.
- ALPHA TEKNOVA, INC. effective income tax rate reconciliation, percent for fiscal 2022 was 3.90%, a 82.59% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Percent 3 month | Effective Income Tax Rate Reconciliation, Percent 3 month as first filed | Effective Income Tax Rate Reconciliation, Percent 6 month | Effective Income Tax Rate Reconciliation, Percent 9 month | Effective Income Tax Rate Reconciliation, Percent 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -1.00% 10-Q · filed 2026-08-06 | -1.00% 10-Q · filed 2026-08-06 | |||
| 2026-03-31 | -1.00% 10-Q · filed 2026-05-07 | ||||
| 2025-12-31 | -0.30% 10-K · filed 2026-03-02 | ||||
| 2025-09-30 | -1.90% 10-Q · filed 2025-11-07 | -1.00% 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | -0.50% 10-Q · filed 2026-08-06 | -0.50% 10-Q · filed 2026-08-06 | |||
| 2025-03-31 | -0.50% 10-Q · filed 2026-05-07 | ||||
| 2024-12-31 | 0.30% 10-K · filed 2026-03-02 | ||||
| 2024-09-30 | 0.10% 10-Q · filed 2025-11-07 | -0.10% 10-Q · filed 2024-11-08 | 0.20% 10-Q · filed 2025-11-07 | ||
| 2024-06-30 | 0.10% 10-Q · filed 2025-08-08 | 0.30% 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 0.40% 10-Q · filed 2025-05-09 | ||||
| 2023-12-31 | 0.80% 10-K · filed 2025-03-07 | ||||
| 2023-09-30 | -0.10% 10-Q · filed 2024-11-08 | 0.00% 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | -0.20% 10-Q · filed 2024-08-13 | 0.20% 10-Q · filed 2023-08-11 | 0.00% 10-Q · filed 2024-08-13 | ||
| 2023-03-31 | 0.20% 10-Q · filed 2024-05-13 | ||||
| 2022-12-31 | 3.90% 10-K · filed 2024-03-27 | ||||
| 2022-09-30 | -1.60% 10-Q · filed 2023-11-13 | 1.60% 10-Q · filed 2022-11-14 | 3.20% 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | 6.00% 10-Q · filed 2023-08-11 | 6.10% 10-Q · filed 2023-08-11 | |||
| 2022-03-31 | 6.10% 10-Q · filed 2023-05-11 | ||||
| 2021-12-31 | 22.40% 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | 21.50% 10-Q · filed 2022-11-14 | 21.00% 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | 20.60% 10-Q · filed 2022-08-11 | 20.50% 10-Q · filed 2022-08-11 | |||
| 2021-03-31 | 20.10% 10-Q · filed 2022-05-12 | ||||
| 2020-12-31 | 24.50% 10-K · filed 2022-03-18 | ||||
| 2020-09-30 | 29.30% 10-Q · filed 2021-11-12 | 23.60% 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | 29.20% 10-Q · filed 2021-08-13 | 16.40% 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |